Transgene Biotek Q2 Results

  • BSE: 526139
  • NSE: -
  • ISIN: INE773D01018
  • Sector: Biotechnology & Drugs
BSE
6.520.03 (0.46%)
Volume16.55 K
Updated: Tue 26 Nov, 2024 | 15:29:24
NSE
This stock is not traded on NSE
Today: 6.51
6.81
52-Wk: 5.79
12.46

Q2 Results Highlights

  • Total Income
    ₹0.06 Cr.
    (18.90%)
  • Operating Profit
    ₹-0.10 Cr.
    (-77.04%)
  • Profit After Tax
    ₹-0.07 Cr.
    (NA%)
  • Operating Margin
    -170.77%
    (-46.69%)
Note: Comparison is on YoY basis

Quarterly - Transgene Biotek Q2 Results

*All figures in crores except per share values
Fiscal PeriodSep 24Jun 23QoQ CompSep 23YoY Comp
Total Revenue 0.060.10-%0.04-%
Selling/ General/ Admin Expenses Total 0.080.08-%0.08-%
Depreciation/ Amortization 0.020.02-%0.02-%
Other Operating Expenses Total 0.050.15-%0.09-%
Total Operating Expense 0.160.25-%0.19-%
Operating Income -0.10-0.15-%-0.14-%
Net Income Before Taxes -0.07-0.14-%-0.13-%
Net Income -0.07-0.14-%-0.13-%
Diluted Normalized EPS -0.01-0.02-%-0.02-%

Recommended For You

    More Recommendations

    Trending Stocks

      Subscribe to Our Newsletter

      Get daily newsletters around different themes from livemint.

      Subscribe
      HomeMarketsPremiumInstant LoanMint Shorts